阴离子纳米载体:针对负电荷癌细胞的潜在方法
Monika Vishwakarma1, Poornima Agrawal1, Sakshi Soni1
1Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, MP, India.
Advances in colloid and interface science
|April 25, 2024
概括
向癌症疗法使用阴离子载体系统来利用癌细胞的负电荷,提高药物特异性并减少副作用. 这些系统提供了超出癌症治疗范围的多功能应用.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- 传统的化疗缺乏特异性,导致健康组织受损.
- 针对性癌症疗法对于改善治疗疗效和患者治疗结果至关重要.
- 癌细胞具有独特的特征,包括更高的负表面电荷,可用于向药物输送.
研究的目的:
- 通过使用新型药物输送系统,审查癌症治疗的创新向方法.
- 探索利用癌细胞独特的负电荷来提高药物特异性.
- 讨论阴离子载体系统在癌症治疗及其他领域的开发和应用.
主要方法:
- 关于癌细胞向和药物输送系统的科学文献的审查.
- 分析癌细胞的物理化学特性,特别是它们的表面电荷.
- 检查设计用于与负电荷癌细胞相互作用的阴离子载体系统.
主要成果:
- 癌细胞表现出明显的负表面电荷,这是由于脂组成的改变和华堡效应造成的.
- 阴离子载体系统通过利用它们的负电荷有效地向癌细胞,增强治疗特异性.
- 这些系统显示出各种应用的潜力,包括蛋白质/递送,成像,光动力学疗法,基因递送和抗菌用途.
结论:
- 阴离子载体系统通过利用癌细胞特异性的负电荷,为向癌症治疗提供了一个有前途的战略.
- 这些多功能系统为除瘤外的广泛生物医学应用提供了潜力.
- 对阴离子载体系统的进一步研究可以导致更有效,更少毒性的治疗干预措施.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


